Whereas the FEN1 inhibitor, SC13 with an IC50 of 4.2 μM, supressed growth of breast cancer cell lines and also sensitised cells to cisplatin, 5-FU and TMZ [57]. The gene discussed is FEN1; the disease is breast carcinoma.